Company overview

Neuréva is a privately held biotechnology company, which conducts drug discovery and drug development for SCI. Neuréva was founded in 2004 as a spin-off of the Institute for Neuroscience of Montpellier (INSERM U583 – France).

Neuréva is situated in Montpellier, home of the oldest medical school in Europe. Its laboratories are located within the Institute for Neuroscience, a new 4000 m2 building dedicated to fundamental research which is integrated to the campus of the Hospital for Neurology Gui de Chauliac (Departments of Neurology, Neurosurgery, Neuroradiology, Nuclear Medicine and Biophysics, Intensive Neurological Care).

Neureva Facilities at the institute for Neuroscience of Montpellier

- Histology and immunochemistry platform

- Surgical and behavior platform

- Animal facilities

- Administrative facilities

- Conference Rooms 

RIO imaging of Montpellier

- Optic, confocal and electron microscopy 

RIO NMR OF Clermond Ferrand

- High field MRI / MRS

Our Associated partners

- Neurological Hospital, CHU Gui de Chauliac - Montpellier

- Institute for Functional Genomics - Montpellier

- CNRS UMR5158 Laboratory of Electronics, Informatics and Imaging LE2l

- Department of Human Biology, Chemistry and Genetics, UTMB, Galveston Texas, USA

Neuréva  R&D drug discovery program is focused on three complementary approaches:

Neuroprotection:  
- A safe lead - a phase I trial 

- More than 100 potential back up compounds

- Strong IP 

Regeneration:

- Early stage preclinical

- 5 molecules in the pipe

- Strong IP

Neuropathic pain: 

- Early stage preclinical 

- 3 molecules in the pipe

- New patents pending